ArticleJournal of geriatric cardiology : JGC2026
Geriatric nutritional risk index associated to long-term prognosis and length of hospitalization in the contemporary transcatheter aortic valve replacement era.
Article in Journal of geriatric cardiology : JGC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalnutrition is a common comorbidity in elderly patients with severe aortic valve stenosis undergoing transcatheter aortic valve replacement (TAVR). The geriatric nutritional risk index (GNRI), a validated and easy-to-use tool, has been previously associated with short/mid-term outcomes in such patients. This study aimed to confirm this association in the long-term in the contemporary TAVR era using new-generation devices and to evaluate its impact on length of hospitalization.
methodsA total of 1090 consecutive patients aged ≥ 65 years undergoing TAVR between October 2015 and December 2021 at a single tertiary center were included. Patients were stratified into two groups based on baseline GNRI: the GNRI > 98 (low-risk) group and the GNRI ≤ 98 (moderate-to-high risk) group. The primary endpoint was all-cause mortality. Secondary endpoints included total length of hospitalization and length of intensive care unit stay. Kaplan-Meier curves and Cox regression models were used to assess survival differences and potential independent predictors.
resultsPatients with GNRI ≤ 98 had significantly higher cumulative mortality rates at all evaluated time points compared to patients with GNRI > 98 (30-day: 6.9%
conclusionsIn this large European cohort, GNRI was confirmed to be an independent predictor for long-term mortality up to five years in the contemporary era of TAVR use with new-generation devices. Hospital stay was longer in patients with lower GNRI. This easy-to-use index could play a valuable role in the preprocedural assessment of patients undergoing TAVR and studies to explore the use of nutritional preprocedural optimization of patients with low GNRI values are warranted.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.